Validation is understood as a lifecycle model instead of an isolated action. Continuous data evaluation replaces gathering and archiving data as evidence.
Risk-based action replaces extensive action for maximum compliance.
[GMP Compliance Adviser, Chapter 7.B.2.1]
You can find out more about this topic:
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business!